Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine plus standard chemotherapy for metastatic colon cancer
IRCT20210819052230N1Phase 2Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of memantine in colorectal cancer (CRC) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: quality of life, body mass index and 3 more. Started Jan 2022; status: completed.
02
Drugs
memantine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on IRCT20210819052230N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210819052230N1.